Evaluation of the Diagnostic Value of Transperineal Prostate Biopsy Guided by Transrectal Ultrasound in Prostate Cancer
Objective:To explore and analyze the effectiveness of transperineal prostate biopsy guided by transrectal ultrasound in the diagnosis of prostate cancer and assess its clinical applicability.Methods:This study was conducted from January 2020 to June 2023.During this period,110 patients diagnosed with prostate cancer were enrolled as subjects from our hospital's records.All 110 patients underwent transperineal prostate biopsy guided by transrectal ultrasound.The diagnostic results,ultrasonographic features,and incidence of complications were recorded and analyzed by the research team.Results:The results showed that in this study,transperineal prostate puncture biopsy was performed under rectal ultrasound guidance.The accuracy of diagnosis was 96.36%(106 cases),and there were 4 cases of missed diagnosis,among which the cancer focus of missed patients was located in the basement,which was difficult to diagnose.In diagnostic junction.The results showed that there were morphological asymmetries and low/isoecho external glands in prostate cancer patients.The patients were followed for one week.Among 110 patients,2 patients had hematuria and 4 patients had acute urinary retention.The total incidence of adverse reactions was 5.45%.Conclusion:Straight enteroultrasound-guided transperineal prostate puncture has shown significant value in the diagnosis of prostate cancer.Sonographic findings show that prostate cancer patients have shape.The characteristics of asymmetry of state and low echo of external gland further confirm the reliability of diagnosis.However,this method also presents some advantages in the application process.The incidence of adverse reactions,such as hematuria and acute urinary retention,was 5.45%.In summary,rectal ultrasound-guided perineal prostatic puncture was performed.It is a diagnostic method with high accuracy and clinical operability,and is expected to play a positive role in the early diagnosis and treatment of prostate cancer.